EBITDA Margin % is calculated as EBITDA divided by its Revenue. Nobleoak Life's EBITDA for the
six
months ended in Dec. 2025 was A$0.0 Mil. Nobleoak Life's Revenue for the
six
months ended in Dec. 2025 was A$252.1 Mil. Therefore, Nobleoak Life's EBITDA margin for the quarter that ended in Dec. 2025 was 0.00%.
Nobleoak Life (ASX:NOL) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Nobleoak Life EBITDA Margin % Related Terms
Nobleoak Life EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Nobleoak Life's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ASX:NOL vs AFL, MET, PRU: EBITDA Margin % Comparison
For the Insurance - Life subindustry, Nobleoak Life's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nobleoak Life EBITDA Margin % vs Insurance Industry
For the Insurance industry and Financial Services sector, Nobleoak Life's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Nobleoak Life's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nobleoak Life (ASX:NOL) has a EBITDA Margin % of 0.00% as of Dec. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Nobleoak Life and its competitors. Over the past decade, Nobleoak Life's EBITDA Margin % has ranged from 18.43 to 30.65. According to the industry distribution chart, Nobleoak Life ranks #67 out of 369 companies in the Insurance industry, placing it in the top 18.2%.
Is Nobleoak Life's EBITDA Margin % too high?
Nobleoak Life's current EBITDA Margin % is 0.00%. Over the past 10 years, this metric has ranged from a low of 18.43 to a high of 30.65. Based on the distribution chart, Nobleoak Life ranks #67 out of 369 companies in the Insurance industry, which is in the top quartile — a strong position relative to peers. Overall, Nobleoak Life has a GF Score™ of 52/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Nobleoak Life's EBITDA Margin % compare to AFL and MET?
According to the Insurance industry distribution chart, Nobleoak Life ranks #67 out of 369 companies for EBITDA Margin %. This places Nobleoak Life in the top 18% of its industry — outperforming the majority of peers. The industry median EBITDA Margin % is 14.81. Historically, Nobleoak Life's own EBITDA Margin % has ranged from 18.43 to 30.65 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for an Insurance company?
The median EBITDA Margin % among Insurance companies is 14.81, based on 369 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Nobleoak Life and its competitors. For the Insurance industry, the median EBITDA Margin % is 14.81 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nobleoak Life's current EBITDA Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nobleoak Life stock overvalued right now?
Based on GuruFocus' analysis, Nobleoak Life (ASX:NOL) is currently considered Significantly Undervalued. The stock's GF Value™ is A$1.76, compared to a current price of A$1.19 — trading 32.7% below its estimated fair value. The current EBITDA Margin % is 0.00%. Nobleoak Life's overall GF Score™ is 52/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Nobleoak Life (ASX:NOL), the current EBITDA Margin % is 0.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Nobleoak Life (ASX:NOL) Overvalued in 2026?
Based on GuruFocus' analysis, Nobleoak Life stock appears to be undervalued.
The current stock price of A$1.19 is trading 32.7% below its estimated GF Value™ of A$1.76.
GuruFocus considers Nobleoak Life to be Significantly Undervalued.
Key valuation signals for ASX:NOL:
EBITDA Margin %: 0.00%
GF Value™: A$1.76 vs. price of A$1.19 (32.7% below fair value)
No single metric tells the full story. See the ASX:NOL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Nobleoak Life Ltd is involved in the manufacture and distribution of Life Insurance products (including death, total and permanent disability, trauma, income protection and business expenses insurance) through both its Direct and Strategic Partner (Advised) channels. The company's segments include Direct Business, Strategic Partnerships, and Genus. It generates maximum revenue from the Direct segment.
52GF Score
Get the complete analysis for ASX:NOL
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:NOL has been successfully added to your 
